Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mangafodipir as Adjunct to FOLFOX6 in Colon Cancer
NCT00671996Phase 2Completed
- Sponsor
- Egetis Therapeutics
- Start
- Jun 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mangafodipir in colon cancer, sponsored by Egetis Therapeutics. Started Jun 2008; status: completed.
02
Drugs
mangafodipir
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00671996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671996.